Melanotransferrin (MTf) or melanoma tumor antigen p97 is a transferrin (Tf) homolog that is found predominantly bound to the cell membrane via a glycosyl phosphatidylinositol anchor. The molecule is a member of the Tf superfamily and binds iron through a single high-affinity iron(III)-binding site. Since its discovery on the plasma membrane of melanoma cells, the function of MTf has remained intriguing, particularly in relation to its role in cancer cell iron transport. In fact, considering the crucial role of iron in many metabolic pathways, e.g., DNA synthesis, it was important to understand the function of MTf in the transport of this vital nutrient. MTf has also been implicated in diverse physiological processes, such as plasminogen activation, angiogenesis and cell migration. However, recent studies using a knockout mouse and posttranscriptional gene silencing have demonstrated that MTf is not involved in iron metabolism, but plays a vital role in melanoma cell proliferation and tumorigenesis. In this review, we discuss the possible biological functions of MTf, particularly in relation to cancer.
Introduction
Melanotransferrin (MTf), or melanoma-associated tumor antigen p97, is a membrane-bound glycoprotein that is a homolog of the transferrin (Tf) family of non-heme Fe-binding proteins (Brown et al., 1982) . MTf was one of the first cell-surface markers associated with melanoma (Brown et al., 1981a) . In fact, it was previously described as an oncofetal antigen, being expressed in only small quantities in normal tissues, but in much larger amounts in neoplastic cells (especially malignant melanoma cells) and fetal tissues (Woodbury et al., 1980; Brown et al., 1981b) .
More recently, there have been reports of MTf protein being identified in normal tissues, including sweat gland ducts (Natali et al., 1987; Alemany et al., 1993) , avian eosinophils (McNagny et al., 1996) , porcine fetal intestinal epithelial cells (Danielsen and van Deurs, 1995) , liver endothelial cells (Sciot et al., 1989; Alemany et al., 1993) , rabbit and mouse cartilage (Kawamoto et al., 1998; Nakamasu et al., 1999) , avian proximal kidney tubules (McNagny et al., 1996) and the normal endothelium and reactive microglia of brains of Alzheimer's disease (AD) patients Kennard et al., 1996; Rothenberger et al., 1996; Yamada et al., 1999) . Normal sera contains very low levels of soluble MTf (sMTf) protein (Brown et al., 1981b) and increased sMTf has been described in patients with AD and arthritis . In addition, MTf has been shown to be expressed at mRNA levels in a wide variety of human tissues (Richardson, 2000) . From a range of 50 normal human tissues, the highest MTf mRNA levels were found in the salivary gland (Richardson, 2000) . Later studies in mice also demonstrated that MTf mRNA levels were high in this tissue as well as the pancreas and epididymis (Sekyere et al., 2005) . Hence, the differential expression of MTf suggests a specific function that may have physiological and pathological indications.
MTf shares many important characteristics with serum Tf, including: (i) a sequence homology of 37-39% with human serum Tf, human lactoferrin (Lf) and chicken Tf; (ii) the MTf gene is located on chromosome 3, as are those for Tf and the transferrin receptor 1 (TfR1); (iii) the presence of many disulfide bonds in MTf that are also present in Tf and Lf; (iv) MTf has an N-terminal Febinding site that is identical to the N-lobe Fe-binding site found in serum Tf; and (v) isolated and purified MTf can bind Fe from Fe(III) citrate complexes (Brown et al., 1981a (Brown et al., , 1982 Rose et al., 1986; Richardson and Baker, 1991a; Food et al., 2002) . These observations suggested that MTf played a role in Fe transport.
The most obvious difference between MTf and serum Tf is that MTf is bound mainly to the cell membrane by a glycosyl phosphatidylinositol (GPI) anchor, whereas Tf is found free in the plasma (Alemany et al., 1993; Food et al., 1994; Kennard et al., 1995; Nakamasu et al., 1999; Yamada et al., 1999) . The sMTf may also be secreted from cells, although at very low levels (Food et al., 1994) . Recent investigations have shown that deletion of the GPI-anchor via genetic engineering resulted in a recombinant sMTf that was far less effective than Tf at donating Fe to cells . In addition, sMTf cannot be bound by the TfR1 nor transferrin receptor 2 (TfR2), despite its high structural homology to Tf Kawabata et al., 2004) .
Due to its high homology with Tf, its ability to bind Fe and its high expression on melanoma cells, MTf was hypothesized to play a role in Fe uptake by these tumor cells (Brown et al., 1982; Rose et al., 1986; Richardson and Baker, 1990; Richardson, 2000) . This was an important idea to investigate, as Fe is critical for DNA synthesis and cancer cell proliferation (Kwok and Richardson, 2002; Kalinowski and Richardson, 2005) . Other reports have suggested that MTf could play a role in endothelial migration and angiogenesis (Sala et al., 2002) , plasminogen activation Michaud-Levesque et al., 2006) , differentiation (McNagny et al., 1996; Suardita et al., 2002) , and MTf may transcytose across the blood-brain barrier (Demeule et al., 2002) . More recently, studies using the MTf knockout (MTf À/À ) mouse and melanoma cells engineered to have low MTf expression suggest the molecule may have a role in proliferation and melanoma tumorigenesis . In this review, we will discuss the molecular character and expression of MTf and its potential biological roles, particularly in relation to melanoma tumorigenesis.
Genomic and molecular organization of MTf
The human MTf gene and its equivalent have been cloned and characterized in several organisms (Table 1) . To date, this gene has been identified in ten organisms, namely human, chimpanzee, rabbit, rhesus monkey, cow, mouse, rat, dog, chicken and zebrafish, where the molecules share 46-88% protein homology to human MTf. Most of the genes for MTf family members are predicted to encode molecules of 721-1540 amino acids in length, whereas the chimp gene is predicted to encode a much larger protein of 2031 amino acids (Table 1) . However, BLAT analysis (database version March 2006) demonstrated the presence of extra sequence within chimp MTf that corresponded to the human discs large homolog 1 (Drosophila, Dlg1) gene. Hence, the large size of chimp MTf as reported in the NCBI database (XM_526438; accessed July 2006) may not be representative of the actual gene. Only human MTf protein has been purified and characterized in detail (Brown et al., 1981a (Brown et al., , 1982 and the software predictions of the size of other MTf family members (Table 1) must be confirmed experimentally. An MTf-like gene has been identified in the fruit fly, Drosophila melanogaster, and also in the mosquito, Anopheles gambiae (Adams et al., 2000) . However, unlike other members of the MTf family, these insect molecules show far lower homology to other MTf family members and the single Fe-binding site is not conserved (Sekyere and Richardson, 2000) . Hence, the role of these MTf-like proteins in insect Fe metabolism is unclear.
The MTf amino acid sequence data from all ten animal species known have been aligned and a phylogenetic tree constructed ( Figure 1a ) by the neighbor-joining method (http://align.genome.jp/) (Nakamasu et al., 1999) . Analysis of this phylogenetic tree shows the relationship of the ten MTf members compared with human Tf, Lf and chicken ovoTf. MTf diverged from the other Tf's at position 'X', whereas fish and avian MTf diverged from mammals at position 'Y' (Figure 1a) . Additionally, it has been previously shown that MTf diverged from Tf after the divergence of vertebrates and invertebrates (Nakamasu et al., 1999) . Hence, there is evidence that in evolutionary terms, MTf is more distantly related to serum Tf than Lf (Lambert et al., 2005a, b) . Considering this, it is possible that the molecular architecture of the Tf molecule could be a useful scaffold for 'building' other molecules with different functions and this is explored further in section 5.
Chromosomal localization and gene structure of MTf
The human MTf gene (also denoted as MFI2) is localized to region q28-29 on the reverse strand of chromosomes 3 and resides in the same region as the Tf and TfR1 genes (Plowman et al., 1983; Yang et al., 1984; Seligman et al., 1986) . It spans over 26 kb and is comprised of 16 exons (Figure 1b ; NCBI GeneID: NM_005929) (Plowman et al., 1983; Le Beau et al., 1986) . Analysis of the mouse MTf gene (mMTf, MFi2) demonstrated that it is similar to hMTf, spanning approximately 26 kb and consisting of 16 exons (GeneID: NM_013900) (Nakamasu et al., 2001) . The hMTf promoter region (601 bp, http://www.genomatix.de/) is mapped from þ 32 to À569, taking the translation initiation codon (AUG) as þ 1. This promoter contains three Sp1 transcription factor-binding sites and a high GC content (71%). However, the minimal region required for promoter activity is defined from positions À204 to À1, which has two potential binding sites for Sp1 (Duchange et al., 1992) . The Sp1 transcription factor is essential for regulating genes with GC boxes, stimulating or repressing transcription at promoters and enhancers and has a role in development and differentiation (Courey et al., 1989; Saffer et al., 1991) .
Furthermore, an enhancer element has also been detected 2 kb upstream from the hMTf promoter region, and its deletion results in impairment of hMTf gene expression in melanoma cell lines (Duchange et al., 1992) . In addition to Sp1, other studies also indicate the presence of three potential AP1 binding sites in the enhancer element of hMTf from À2312 to À2268 bp (Roze-Heusse et al., 1996) .
The MTf, Tf and TfR1 genes colocalize to the same chromosome in a number of different organisms. In fact, in human, chimpanzee, rhesus monkey, mouse, rat, dog and chicken, TfR1 colocalizes with MTf on chromosome 3, 3, 2, 16, 11, 33 and 9, respectively (Table 1) . Interestingly, Tf that has homology to MTf colocalizes to the same chromosome in only humans, chimpanzees, rhesus monkey, cow and chicken (Table 1) . However, the significance of this observation has not been elucidated.
MTf gene transcription
The hMTf gene encodes two transcripts: (i) a 16-exonlong isoform, hMTf (2377 bp, Genbank Accession: NM_005929) and (ii) a shorter seven-exon isoform, hDMTf (1651 bp, Genbank accession NM_033316) (Sekyere et al., 2003) . The most recent Genbank information describes the full-length hMTf transcript as 2377 bp (coding region 70-2283). However, the initial studies by Rose et al. (1986) identified a polyadenylated transcript of over 4 kb, the additional sequence being 3 0 -untranslated region. In the hDMTf transcript, the first six exons are identical to those of hMTf (Sekyere et al., 2005) . However, the seventh and last exon, termed 6b, is composed of intron 6 sequence ( Figure 1b ). The sequence of exon 6b has an in-frame termination signal resulting in the truncated hDMTf transcript .
Recent studies have aimed to characterize hMTf transcripts and their expression patterns in normal human tissues and a variety of tumor cell lines (Sekyere et al., 2005) . Northern blot analysis of 12 normal tissues demonstrated two transcripts across all human tissues assessed, at approximately 3 and 4 kb (Sekyere et al., 2005) . Additionally, a third transcript was detected in the heart and skeletal muscle at approximately 2 kb (Sekyere et al., 2005) . This smaller mRNA may equate to the hDMTf transcript and was not detected in the other tissues examined (Sekyere et al., 2005) . Alternative splicing of the pre-mRNA accounts for the two known hMTf transcripts that were observed at 4 kb (Rose et al., 1986) and 2 kb (Sekyere et al., 2005) , whereas the presence of the 3-kb transcript could only be explained by the use of alternative polyadenylation sites (Sekyere et al., 2005) . Further, in nine tumor cell lines assessed, the hDMTf transcript was detected by RT-PCR at high levels in the melanoma cell lines, SK-MEL-2 and SK-MEL-28, but was absent or only very slightly expressed in the other cell types (Sekyere et al., 2005) .
The physiological significance of the MTf splice variants in both normal tissues and cell lines remains unknown and it is unclear whether the hDMTf transcript leads to a functional gene product. However, examining Figure 1 (a) The neighbor-joining tree of MTfs and the other Tf family members. Whole and partial protein sequences of Tf superfamily members available in the databases were aligned to construct a phylogenetic tree using global alignment by the neighbor-joining method (http://clustalw.genome.jp/). (b) BLAT analysis arising from the human MTf (hMTf) and mouse MTf (mMTf) genes. The long hMTf and mMTf transcripts consist of 16 exons, whereas hDMTf consists of seven exons. The hDMTf transcript is composed of exons 1-6 and a final 3 0 exon consisting of part of intron-6 from hMTf which was denoted previously as exon-6b . the resultant protein sequence, the truncated product arising from the hDMTf transcript has lost one Febinding residue (His-279) and has no GPI-anchor motif, and thus, may not be membrane-bound . In fact, Kyte-Doolittle analysis indicated that if a protein resulted from the translation of hDMTf, it would have increased hydrophilicity compared with the fulllength protein encoded by hMTf, and may be a soluble molecule (Sekyere et al., 2005) . However, the sMTf identified from spent culture supernatants of melanoma cells, is much larger (80-97 kDa) (Food et al., 1994) than that predicted for the protein product of hDMTf (302 amino acids; approximately 30 kDa; Table 1 ).
Protein structure of MTf Like other members of the Tf superfamily (Morgan, 1981; Richardson and Ponka, 1997) , the hMTf protein is composed of two major lobes (Rose et al., 1986; Baker and Lindley, 1992) . The molecule consists of 738 amino acids, with a predicted molecular weight of 80.2 kDa. The protein can be divided into four key regions: (i) a 19-residue hydrophobic signal peptide; (ii) an extracellular N-terminal consisting of 342 amino acids that contains the functional Fe-binding site; (iii) an extracellular C-terminal of 352 amino acids; and (iv) a 25-residue hydrophobic GPI-anchor domain present on the membrane-anchored form of the protein (Rose et al., 1986) . The N-and C-terminals share high internal homology that includes 14 cysteine residues, most of which are also conserved across the Tf family of proteins (Brown et al., 1982; Rose et al., 1986; Bailey et al., 1988; .
In addition to the membrane-bound form of hMTf, sMTf is probably a secreted form of the protein that apparently is not passively shed from the cell (Food et al., 1994) . The sMTf has been detected in spent culture medium from melanoma cells, as well as in urine, saliva, serum and cerebrospinal fluid (Food et al., 1994; Yamada et al., 1999; Kim et al., 2001; Desrosiers et al., 2003) . At present, it is unclear whether the soluble form seen in cell-culture supernatants is the same molecular species that is seen in vivo, e.g., in serum .
The first observation of hMTf using reducing SDS-PAGE analysis showed that the protein migrated at approximately 97 kDa (Woodbury et al., 1980) . In later studies using non-reducing conditions, Desrosiers et al. (2003) demonstrated two MTf isoforms that migrate at 79 and 82 kDa and are recognized by the specific antiMTf monoclonal antibody L235. These MTf isoforms are likely the result of post-translational modifications such as differential glycosylation (Desrosiers et al., 2003) . In fact, glycosylation sites have been identified at residues 38 and 135 of the N-terminal and residue 515 in the C-terminal (Brown et al., 1981a; Rose et al., 1986) .
A major difference between MTf and other members of the Tf family is the ability of MTf to bind only one ferric atom in its N-terminal region . As found in Tf, the critical Fe-binding ligands in the N-terminal of MTf consists of the DYRYH motif (Table 2) , which is composed of Asp78, Tyr107, Arg136, Tyr210 and His279 . In contrast to Tf, the C-terminal of MTf consists of SYSYH, in which Asp-421 and Arg-482 are replaced by serine resulting in a general disruption of H-bonding and loss of the Fe-binding motif (Bailey et al., 1988; Baker and Lindley, 1992; Nakamasu et al., 1999; Sekyere and Richardson, 2000) . Analysis of the protein sequence encoded by the hDMTf transcript suggests that the potential protein product does not bind Fe, as the His279 residue has been replaced by valine (Sekyere et al., 2005) .
The Fe-binding site of MTf, like other members of the Tf family (Morgan, 1981) , has been suggested to be capable of binding other metal cations (Richardson, 2000) . In addition to this, a putative zinc(II)-binding motif (HExxH) GenBank accession numbers (protein ID): human Tf -NP_001054; cockroach Tf -A47275; human Lf -NP_002334; chicken ovoTf -NP_990635; other proteins (see Table 1 ). (Garratt and Jhoti, 1992; Nappi and Vass, 2000) . If metalloprotease activity is an important function of MTf, one may expect the motif to be conserved across species. However, this motif is absent in the mouse, chicken and rabbit, suggesting that at least in these organisms, MTf probably has no significant metalloprotease activity (Sekyere and Richardson, 2000) .
Expression and localization of MTf

GPI-anchored MTf
MTf was initially thought to be bound to the plasma membrane through its hydrophobic protein tail (Brown et al., 1982) . Evidence for membrane anchoring through a GPI moiety was published over 10 years later (Alemany et al., 1993; Food et al., 1994) . MTf was demonstrated to attach to the cell surface via a GPIanchor through studies examining: (i) the sensitivity of the protein to bacterial phosphatidylinositol-specific phospholipase C (PI-PLC), which is a common method to cleave GPI-anchored proteins from membranes; (ii) biosynthetic labeling with [ 3 H]ethanolamine; and (iii) partitioning of MTf in Triton X-114 (Low, 1989; Food et al., 1994) .
The GPI-anchor may be important in MTf function, as GPI-anchors can regulate cell-surface localization, transmembrane signaling, surface-molecule turnover and biological function of membrane-bound proteins. The family of GPI-anchored proteins form a diverse array of molecules that includes membrane-associated enzymes, adhesion molecules, activation antigens, differentiation markers, protozoan coat components and other miscellaneous glycoproteins (Brown and Waneck, 1992) .
The GPI-anchor imparts some functional characteristics to proteins, such as: (i) a strong apical targeting signal in polarized epithelial cells (Lisanti et al., 1989 (Lisanti et al., , 1990 ; (ii) the ability to concentrate into specialized lipid domains in the membrane, including the so-called 'smooth pinocytotic vesicles' (caveolae) (Sargiacomo et al., 1993) ; (iii) GPI-anchored proteins may act as activation antigens in the immune system and may modulate antigen presentation by major histocompatibility complex molecules (Lisanti et al., 1989; Brown and Waneck, 1992; Brown, 1993; Loertscher and Lavery, 2002) ; and (iv) cleavage of GPI-anchor by PI-phospholipase C or PI-phospholipase D may generate second messengers for signal transduction (Low and Huang, 1991; Sharom and Lehto, 2002) . To date, the biological roles of MTf in relation to the presence of its GPI-anchor remain unresolved, although it is of interest that MTf is expressed on many epithelial surfaces (e.g., gland ducts; Alemany et al., 1993; Sekyere et al., 2005) where apical targeting may be important in its function.
Soluble MTf
As discussed previously, sMTf has been identified in cell-culture supernatants (Food et al., 1994; Liao, 1996) and in the serum of patients with arthritis and AD Kim et al., 2001) . A recent study examining the role of genetically engineered sMTf in Fe uptake by cells showed that despite its homology to Tf, sMTf does not bind to the TfR1 nor any other high-affinity receptor . In fact, compared with Tf, sMTf was inefficient at donating Fe to cells and was non-specifically internalized by melanoma cells and reticulocytes (Richardson and Morgan, 2004) . Moreover, sMTf was degraded by the lysosome . This is in contrast to Tf, which is internalized and largely re-cycled in many cell types (Morgan, 1981) , including melanoma cells (Richardson and Baker, 1991b) .
It has been previously shown that sMTf protein does not contain a GPI-anchor signal and is not likely to originate from shedding of the membrane-bound form (Alemany et al., 1993; Food et al., 1994) . However, it is still unclear how sMTf may arise and its precise function and physiological significance is unknown. Considering the genesis of sMTf, defects in either the biosynthesis of the GPI-anchor, or the addition of the anchor to the polypeptide chain are known to occur (Miyata et al., 1994; Ware et al., 1998) and could potentially result in release of the soluble form of the molecule. Secondly, the presence of GPI-specific phospholipase D (GPI-PLD) in mammalian plasma which recognizes a conserved portion of the anchor (Metz et al., 1991) could, at least in part, account for sMTf.
Functional role of MTf: melanoma iron transport and metabolism
One of the well-characterized properties of hMTf is the sequence similarity with members of the Tf superfamily and its ability to bind one Fe-atom (Brown et al., 1982) . A general hypothesis initially existed that MTf may be overexpressed on melanoma cells to assist with their increased Fe requirements for proliferation (Brown et al., 1982; Richardson and Baker, 1990; Sekyere and Richardson, 2000) .
A variety of in vitro studies have been performed to ascertain the relationship between MTf and Fe metabolism in melanoma cells (Brown et al., 1982; Richardson and Baker, 1990, 1991a, b) . Iron uptake was examined in the SK-MEL-28 cell line that express the highest levels of naturally produced MTf known to date (3.8 Â 10 5 binding sites per cell; (Brown et al., 1982) . Iron uptake in this cell line was found to occur by two processes consistent with: (i) receptor-mediated endocytosis of the Tf-TfR1 complex and (ii) adsorptive pinocytosis of Tf (Richardson and Baker, 1990 , 1991a , b, 1992a . A pronase-sensitive, temperature-dependent, membrane-bound Fe-binding component that was consistent with MTf was also identified, although it could not efficiently donate Fe to the cell from Tf or low-molecular-weight Fe complexes (Richardson and Baker, 1990 , 1991b , 1992b . Indeed, removal of MTf from the cell with PI-PLC had no significant effect on Fe uptake from 59 Fe-citrate (Richardson, 2000) . Collectively, these studies demonstrated that MTf did not play a significant role in Fe uptake by melanoma cells.
It is of interest to note that Kennard et al. (1995) showed that MTf-transfected Chinese hamster ovary (CHO) cells could internalize Fe from Fe(III) citrate complexes. These CHO cells expressed 1.2 Â 10 6 MTf molecules per cell, a level three-to four-fold higher than that of the most highly expressing, naturally-derived melanoma cell line, SK-MEL-28 (300-380 000 sites/cell; Brown et al., 1981a; Sekyere and Richardson, 2000) . However, after an incubation of 240 min, the Fe uptake from 59 Fe-citrate was only 2.4 times greater than the control CHO cells not expressing MTf (Kennard et al., 1995) . Furthermore, hyper-expression of MTf did not result in any increase in Fe uptake from Tf when compared with control cells (Kennard et al., 1995) . These studies again indicated that the role of MTf in Fe uptake was not marked.
Additional investigations were conducted to examine whether MTf expression in SK-MEL-28 melanoma cells was regulated like molecules involved in Fe uptake, e.g., TfR1 (Seligman et al., 1986; Richardson, 2000) . Irrespective of intracellular Fe or cellular proliferation status, MTf mRNA or protein expression was not regulated like TfR1, which is increased by Fe-deficiency or during proliferation (Seligman et al., 1986; Richardson and Ponka, 1997; Richardson, 2000) . In addition, the expression of MTf mRNA amongst tissues was shown to be very different to TfR1 mRNA, with the molecule not being expressed at marked levels in tissues with high Fe requirements (e.g., placenta, liver or bone marrow) (Richardson, 2000) . Other studies also suggest that MTf does not play a key role in Fe metabolism. For instance, unlike TfR1 which is upregulated to supply Fe for DNA synthesis in the S phase (Neckers and Cossman, 1983) , MTf expression remained constant throughout the cell cycle (Kameyama et al., 1986) . All these data demonstrate that MTf expression was not regulated in a way that would be expected if it were playing a vital role in Fe uptake. The in vitro data described above suggested that MTf played little role in Fe transport and metabolism. However, until recently, nothing was known regarding the role of MTf in Fe metabolism in vivo. Recent data published on the characterization of an MTf À/À mouse showed that the mice were viable, fertile and developed normally, with no morphological or histological abnormalities Sekyere et al., 2006) . Assessment of Fe indices, tissue-Fe levels, hematology and serum chemistry parameters demonstrated no differences between MTf À/À and MTf þ / þ mice, suggesting that MTf was not essential for Fe homeostasis and metabolism Sekyere et al., 2006) . Furthermore, Fe status was measured indirectly by examining the Fe-regulated gene, TfR1, at the mRNA and protein levels, and was found to be the same when compared with the wild-type counterparts (MTf þ / þ ) . Hence, ablation of MTf expression does not affect Fe pools that control TfR1 expression, nor was there any marked alterations in the expression of other genes associated with Fe metabolism .
The absence of a phenotype, and particularly any neurological changes in the MTf À/À mouse, question the suggestion that MTf plays a significant role in Fe transport across the blood-brain barrier (Moroo et al., 2003) . Results obtained from the MTf À/À mouse support other studies demonstrating that brain Fe uptake from MTf is not appreciable when compared with that from serum Tf (Richardson and Morgan, 2004) . In fact, recent studies have demonstrated that the transcytosis of sMTf across the mouse blood-brain barrier is not significant (Pan et al., 2004; Richardson and Morgan, 2004) , which is in contrast to earlier work by others (Demeule et al., 2002 . Hence, serum Tf but not sMTf, is the primary source of Fe for the brain, in accordance with earlier literature (Morgan, 1981; Beard et al., 1993) .
Collectively, a wide variety of studies in vitro and in vivo have demonstrated that despite the presence of a high-affinity Fe-binding site which is structurally and functionally similar to that in Tf , MTf does not play an essential role in Fe transport and metabolism.
New insights into MTf function: a role in tumorigenesis
Cell migration and proliferation, plasminogen activation and angiogenesis Melanoma tumors are highly vascularized and there is a correlation between angiogenesis and metastatic potential (Ribatti et al., 1992; Denijn and Ruiter, 1993; Neitzel et al., 1999) . Investigations on the effect of recombinant sMTf on angiogenesis in chick chorioallantoic membrane and chemotactic cell migration using the Boyden chamber assay suggested that recombinant sMTf in vitro exerts: (i) an angiogenic response quantitatively similar to that elicited by fibroblast growth factor-2 (FGF-2) and (ii) induces chemotactic migration of vascular cells (Sala et al., 2002) . These data also suggested that MTf and vascular endothelial growth factor-1 (VEGF1) may play a role in various stages of melanoma progression. In fact, VEGF1 is a known stimulator of migration and angiogenesis in melanoma (Birck et al., 1999; Graeven et al., 2001) . Further, it was concluded by Sala et al. (2002) that recombinant sMTf may participate in the vascularization of solid tumors.
A role for sMTf in angiogenesis and cell migration has been suggested to occur through its interaction with the low-density lipoprotein receptor-related protein and the urokinase:plasminogen activator:urokinase receptor complex . During the past decade, there has been increasing evidence for the involvement of the urokinase-type plasminogen activator (uPA) system in cancer metastasis (Andreasen et al., 1997) . The urokinase:plasminogen activator:urokinase receptor system can enhance cell migration and may have an important role in angiogenesis (Stahl and Mueller, 1994; Andreasen et al., 2000; Choong and Nadesapillai, 2003) . In fact, the uPA, via the generation of plasmin, has been suggested to play a critical role in the extracellular matrix dissolution mediated by malignant melanoma cells (Montgomery et al., 1993) . The uPA molecule is a 50-kDa serine proteinase that is one of two types of plasminogen activator (the other being tissue plasminogen activator; tPA) which is able to convert the ubiquitous pro-enzyme, plasminogen, into plasmin which can degrade a range of proteins (Andreasen et al., 1997) . Plasminogen activation is thought to occur on the cell surface, where a specific urokinase receptor localizes and enhances uPA activity.
It has been reported that membrane-bound MTf acts as a binding site for plasminogen on the cell surface and enhances its activation to plasmin (Figure 2) Michaud-Levesque et al., 2005) . The process involved a specific interaction between sMTf with both pro-uPA and plasminogen that stimulates plasminogen activation by decreasing the K m of pro-uPA for plasminogen and by increasing the V max of the reaction . Hence, MTf may target the formation of plasmin to the cell surface and protect it from inactivation by natural inhibitors (MichaudLevesque et al., 2005) . Interestingly, sMTf was shown to antagonize this process, demonstrating that the balance between endogenous MTf and sMTf could modulate cell migration in melanoma and endothelial cells (Figure 2) MichaudLevesque et al., 2005) . However, the physiological significance remains unclear, as the concentration of sMTf in the serum is exceedingly low . Critically, in all these studies examining angiogenesis and plasminogen activation and the effect of sMTf on these processes, it is notable that the Fe status of sMTf was unspecified. It is known that Fe-binding to the Tf superfamily of proteins results in marked conformational changes that affect biological activity (Baker and Lindley, 1992) . Hence, controlled studies examining the Fe-status of sMTf need to be carried out to clearly delineate the role of this protein in angiogenesis, cell migration and plasminogen activation.
A recent investigation examining the role of sMTf in tubulogenesis in vitro and angiogenesis in vivo has demonstrated that it can antagonize the pro-angiogenic effects of membrane-bound MTf expressing cells (Michaud-Levesque et al., 2006) . The mechanism of this process entails disruption of the balance between membrane-bound MTf and sMTf, resulting in a reduction of plasminogen activation by tPA at the cell surface. This results in the limitation of the proangiogenic activity of MTf by sMTf and thus may provide a therapeutic avenue for limiting tumor progression or growth (Michaud-Levesque et al., 2006; Figure 2 ). These authors have also shown that sMTf could inhibit in vitro tubulogenesis of human umbilical vessel endothelial cells (Michaud-Levesque et al., 2006) . Furthermore, sMTf was shown to inhibit neovascularization induced by SK-MEL-28 melanoma cells, basic fibroblast growth factor or VEGF1 (Michaud-Levesque et al., 2006) . However, these results are in contrast to previous studies by others which showed that sMTf itself was pro-angiogenic and involved VEGF1 (Sala et al., 2002) . In addition, there appear to be some paradoxical results from the same laboratory, with activation of plasminogen by pro-uPA being increased by sMTf , whereas a later study indicated that sMTf decreased plasminogen activation . Clearly, further work is required to clarify the role of sMTf and membrane-bound MTf in Figure 2 Overview of the postulated role of MTf in plasminogen activation and angiogenesis. It has been proposed that membranebound MTf binds plasminogen and stimulates activation through tPA and/or uPA, thereby increasing levels of plasmin (MichaudLevesque et al., 2005 (MichaudLevesque et al., , 2006 . This could result in fibrinolysis, matrix degradation and endothelial cell detachment (Michaud-Levesque et al., 2006) . These processes may facilitate tumor-cell invasion, angiogenesis and metastasis. Studies with recombinant sMTf may inhibit the above-mentioned processes by possibly competing with membrane-bound MTf for plasminogen (Michaud-Levesque et al., 2006) . This could provide a potential therapeutic strategy to prevent angiogenesis, metastasis and tumor growth.
Melanotransferrin: a 25-year hallmark Y Suryo Rahmanto et al plasminogen activation and angiogenesis. It is also important to note that recombinant sMTf may not represent the physiological form of MTf that is present on the membrane and at very low levels in the serum. Hence, the significance of these findings remains unknown. Nevertheless, at high doses, recombinant sMTf may be a therapeutic strategy to inhibit angiogenesis and tumor growth (Michaud-Levesque et al., 2006) .
MTf and its role in melanoma tumorigenesis
Although there was no obvious phenotype in the MTf À/À mouse Sekyere et al., 2006) , the function of MTf may only become apparent in cell types where it is highly expressed, such as melanoma. Recently, Dunn et al. (2006) have carried out studies in order to understand the function of MTf using two different models, namely the MTf À/À mouse and posttranscriptional gene silencing in the melanoma cell line, SK-MEL-28.
In this study, microarray analysis was carried out using brain tissues from six female littermate mice comprising four MTf À/À and two MTf þ / þ animals . Following genome-wide microarray screening, Dunn et al. (2006) performed semi-quantitative RT-PCR analysis to confirm the gene array results and showed that the genes: myocyte enhancer factor-2a (Mef2a), transcription factor-4 (Tcf4) and glutaminase (Gls) were upregulated, whereas the apolipoprotein D (Apod) gene was downregulated compared with their wild-type littermates (Figure 3) The products of these genes have roles in transcription, differentiation and development, regulation of cellular metabolism, transport and cell adhesion (Black and Olson, 1998; Zhao et al., 1999; Naya et al., 2002) . Of these genes, two were identified as encoding transcription factors, namely Mef2a and Tcf4 (Black and Olson, 1998; Mann et al., 1999) . The Mef2a transcription factor is highly expressed in muscle tissues and is involved in fetal cardiac development, calcium-signaling and the MAP kinase pathways (Black and Olson, 1998b; Mann et al., 1999; Zhao et al., 1999; Furumura et al., 2001; Naya et al., 2002) . This transcription factor is suggested to be important in cell proliferation, differentiation and survival (McKinsey et al., 2002) . The Tcf4 gene product plays a role in the Wnt signaling pathway (Graham et al., 2001 ) and the regulation of melanocyte differentiation (Furumura et al., 2001) . The transcription factor, Tcf4, is expressed at high levels in some cancers and functional genomic investigations demonstrated that this molecule has a role in cell proliferation (Mann et al., 1999) .
The other two genes showing differential expression, namely Gls and Apod, encode proteins that have been demonstrated to play a role in proliferation. Glutaminase has been found to be highly expressed in the mitochondria of tumor cells immediately before the maximum rate of proliferation is achieved (Medina et al., 1992; Aledo et al., 1994; Kvamme et al., 2000) . Conversely, Apod inhibits proliferation and is associated with transporting sterols, steroids and arachidonic acid for tissue repair (Sugimoto et al., 1994; Terrisse et al., 1998) . The upregulation of Gls and downregulation of Apod in the knockout mouse compared with the wild-type indicates a direct or indirect response to gene deletion and suggests some role for MTf in proliferation (Figure 3) . Figure 3 The MTf knockout mouse and gene array studies indicate that MTf has no essential role in iron metabolism but could be necessary for cellular growth and proliferation. Although MTf is a Tf homolog that binds Fe with high affinity, the MTf À/À mouse exhibits no phenotypic changes that are typical of alterations of Fe metabolism . In addition, there is no change in the expression of genes associated with Fe metabolism or homeostasis, suggesting that MTf has other roles . Gene array studies on the MTf À/À mouse compared with wild-type littermates indicate that the genes, myocyte enhancer factor-2a (Mef2a), transcription factor-4 (Tcf4) and glutaminase (Gls) were upregulated, whereas the apolipoprotein D (Apod) gene was down-regulated . The products of these genes are known to have roles in cell survival, differentiation and proliferation. Although their exact interactions with MTf remain unclear, these changes in expression could be compensating for loss and/or gain of function induced by MTf ablation.
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Using post-transcriptional gene silencing to downregulate MTf in melanoma cells resulted in the inhibition of proliferation and cell migration . Potentially, these observations could be explained by alterations in gene expression observed in the MTf À/À mice compared with MTf þ / þ littermates. In fact, as found in the MTf À/À mouse, hMEF2A and hTCF4 were upregulated in melanoma cells with decreased MTf expression. These data support the relationship between MTf and the transcription factors observed in the MTf À/À mouse . Furthermore, in vivo studies using MTf down-regulated melanoma cells resulted in significantly reduced initiation and tumor growth in nude mice, indicating that MTf plays a role in melanoma tumorigenesis .
Considering the role of MTf in proliferation, it is notable that evidence from hyper-expression studies using melanoma cells suggested that increased MTf expression results in accelerated growth (Estin et al., 1989) . In contrast, MTf hyper-expression in CHO cells did not increase proliferation (Kennard et al., 1995) . These data support results suggesting that the role of MTf may only be obvious in melanoma cells where it is highly expressed . To conclude, it is intriguing that MTf plays a role in tumorigenesis, but further studies are required to examine the precise molecular pathways involved.
Summary
Over the past 25 years, the biological function of the Tf homolog, MTf, has remained unclear. Although the molecule specifically binds Fe(III), studies in cell culture indicate that neither the soluble or membrane-bound forms of MTf are significantly involved in cellular Fe uptake. However, we cannot rule out the role of Fe in MTf function, e.g., Fe may be required for correct conformational folding of this protein. Therefore, a thorough study examining how Fe status affects MTf conformation and/or functions needs to be initiated.
The recent characterization of the MTf À/À mouse indicates that MTf does not play an essential role in Fe metabolism or homeostasis in vivo under normal physiological or Fe-overload conditions. MTf has been implicated in a diverse range of biological processes and emerging data indicates that it has roles in angiogenesis, cellular proliferation and tumorigenesis. In summary, while the exact mechanisms of MTf function in cancer biology remain to be elucidated, important avenues of investigation can now be initiated to pursue its role(s).
